Cadence Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cadence Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,686	Closed	-$1.04M	–	417
2020 Q2	$1.04M	Sell	10,686 -6	-0.1%	-$558	0.15%	210
2020 Q1	$888K	Sell	10,692 -278	-3%	-$27.1K	0.15%	217
2019 Q4	$1.22M	Sell	10,970 -229	-2%	-$23.6K	0.13%	221
2019 Q3	$1.11M	Sell	11,199 -227	-2%	-$22.5K	0.16%	235
2019 Q2	$1.13M	Buy	11,426 +29	+0.3%	+$2.77K	0.11%	251
2019 Q1	$1.26M	Hold	11,397	–	–	0.11%	243
2018 Q4	$1.05M	Buy	+11,397	New	+$1.15M	0.11%	263

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Cadence Capital Management's PRAH Position: Q3 2020 in Review

Cadence Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 10,686 shares — an estimated $1.04M sold.

Cadence Capital Management first reported a position in PRAH in Q4 2018 and held it in 7 quarters. The position peaked at $1.26M in Q1 2019. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

Cadence Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
Cadence Capital Management sold 10,686 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $1.04M.
Cadence Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 7 quarters.
Cadence Capital Management's PRA Health Sciences, Inc. position peaked at $1.26M in Q1 2019.
281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.